newsfilter
← Latest News
ACCESS Newswire·

Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

According to the NIH, Acute myocardial infarction is a major cause of death, affecting nearly 3 million Americans each year and resulting in over a million deathsTrial demonstrates dramatically higher and more